Prosecution Insights
Last updated: April 19, 2026
Application No. 18/560,218

COMPOSITE SURFACE-TREATED INORGANIC POWDER

Non-Final OA §103§112
Filed
Nov 10, 2023
Examiner
BERRIOS, JENNIFER A
Art Unit
1613
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Tayca Corporation
OA Round
1 (Non-Final)
37%
Grant Probability
At Risk
1-2
OA Rounds
3y 8m
To Grant
88%
With Interview

Examiner Intelligence

Grants only 37% of cases
37%
Career Allow Rate
297 granted / 796 resolved
-22.7% vs TC avg
Strong +50% interview lift
Without
With
+50.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 8m
Avg Prosecution
74 currently pending
Career history
870
Total Applications
across all art units

Statute-Specific Performance

§101
1.2%
-38.8% vs TC avg
§103
52.4%
+12.4% vs TC avg
§102
9.3%
-30.7% vs TC avg
§112
21.9%
-18.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 796 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant's election with traverse of Group I, claims 1-8, in the reply filed on 12/12/2025 is acknowledged. The traversal is on the ground(s) that it would not be an undue burden to examine the full scope of the application. This is not found persuasive because search burden is not a requirement that needs to be met when restricting a 371 application. The examiner has demonstrated that the special technical feature does not make a contribution over the prior art, as such restriction is proper. Applicant remarks that the dual dispersibility and unique sensory property represents a distinguishing feature of the claimed over the prior art. THIs is not persuasive as it is unsupported by factual evidence. The requirement is still deemed proper and is therefore made FINAL. Claim 9 is withdrawn from further consideration pursuant to 37 CFR 1.142(b), as being drawn to a nonelected group, there being no allowable generic or linking claim. Applicant timely traversed the restriction (election) requirement in the reply filed on 12/12/2025. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 6 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 6 recites “one or more kinds selected from…” the use of the word “kinds” renders the claim indefinite as its unclear if the selection is limited to those listed or if it includes derivatives of those listed. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 1-8 is/are rejected under 35 U.S.C. 103 as being unpatentable over JP2010059272. JP’272 is cited on the 11/10/2023 IDS. JP’272 discloses a surface treated inorganic oxide (i.e. main constituent) which is surface treated with a sulfur containing organic silane compound and at least one hydrophobizing agent selected from the groups consisting of fatty acids, higher alcohols, polyether’s and surfactants (Abs). The treatment of the particle surface of the silica allows for excellent dispersibility [0014]. Regarding claim 1: JP’272 teaches the use of silica as the inorganic oxide and teaches that silica has silanol groups on the particles surface and surface treatment with hydrophobic agents helps with dispersibility (which reads on based material powder being an inorganic material) [0002]. The hydrophobic treatment can be at least one of a higher fatty alcohol such as stearyl alcohol (reading on higher aliphatic alcohol) and cationic surfactants [0029-0030]. As JP’272 teaches the use of “at least one” treatment, it would have been prima facie obvious to use two of the treatments taught to be suitable for use, such as stearyl alcohol and a cationic surfactant. Regarding claim 2: Claim 2 recites an emulsion viscosity ratio which appears to be a resultant property of mixing the claimed powder with water under specific conditions. As the prior art makes obvious the claimed composite powder having the same structural limitations (i.e. the same base material with the same surface treatments and overlapping surface treatment to base material powder ratio, see claims below), the powder claimed and the powder of the prior art are expected to have the same properties absent evidence to the contrary. The U.S. Patent Office is not equipped with analytical instruments to test prior art compositions for the infinite number of ways that a subsequent applicant may present previously unmeasured characteristics. When as here, the prior art appears to contain the exact same ingredients and applicant's own disclosure supports the suitability of the prior art composition as the inventive composition component, the burden is properly shifted to applicant to show otherwise. Regarding claims 3-4: JP’272 teaches that a suitable cationic surfactant for use includes distearyl dimethyl ammonium salt, wherein the salts include bromide and chloride, thus the use of distearyl dimethyl ammonium chloride is prima facie obvious. Regarding claim 5: As discussed above, JP’272 makes obvious the use of stearyl alcohol (C18). Regarding claim 6: As discussed above, JP’272 makes obvious the use of silica as the inorganic oxide. Regarding claims 7-8: JP’272 teaches using 1-20, preferably 2-10, parts by weight of the hydrophobic agent based on 100 parts of the silica (i.e. base material). As JP’272 makes obvious using a mixture of agents, it would have been prima facie obvious to use this mixture in a total amounts of 1-20 parts, preferably 2-10parts, based on 100 parts silica and this provides amounts of aliphatic alcohol and cationic surfactant which overlap with the claimed ranges and overlapping ranges are prima facie obvious absent criticality. Conclusion No claims are allowable. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Jennifer A Berrios whose telephone number is (571)270-7679. The examiner can normally be reached Monday-Thursday from 9am-4pm and Friday 9am-3:30pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Brian Kwon can be reached at (571) 272-0581. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JENNIFER A BERRIOS/Primary Examiner, Art Unit 1613
Read full office action

Prosecution Timeline

Nov 10, 2023
Application Filed
Mar 11, 2026
Non-Final Rejection — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599546
HAIR TREATMENT COMPOSITIONS, KITS THEREOF, AND METHODS THEREOF
2y 5m to grant Granted Apr 14, 2026
Patent 12589057
COSMETIC COMPOSITION OF LIQUID CRYSTAL LIPID PARTICLES FOR PERSONAL CARE APPLICATIONS
2y 5m to grant Granted Mar 31, 2026
Patent 12588675
SYNERGISTIC ANTIBACTERIAL ACTIVITY OF MEDIUM POLARITY OILS IN COMBINATION WITH ANTIBACTERIAL AGENTS ON BACTERIAL BIOFILMS
2y 5m to grant Granted Mar 31, 2026
Patent 12576018
ACTIVE AGENTS FOR SKIN AND HAIR CARE WITH SENSORY MODIFYING PROPERTIES
2y 5m to grant Granted Mar 17, 2026
Patent 12551426
METHOD FOR TREATING HAIR, COMPRISING THE APPLICATION OF A FIRST AGENT (A) HAVING A SILANE AND A CHROMOPHORIC COMPOUND, AND A SECOND AGENT (B) HAVING A FILM-FORMING POLYMER
2y 5m to grant Granted Feb 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
37%
Grant Probability
88%
With Interview (+50.3%)
3y 8m
Median Time to Grant
Low
PTA Risk
Based on 796 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month